Efficacy of Botox versus Placebo for Treatment of Patients with Major Depression

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

TCTR

Registry ID

TCTR20170409001

Enrollment

Registered

2017-04-09

Start date

2017-04-08

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Botox Treatment Major depression Botox Treatment Major depression

Interventions

Botox injection,placebo

Experimental Drug,Placebo Comparator Drug

Botox Group,placebo

Eligibility

Sex/Gender

All

Age

30 Years to 50 Years

Inclusion criteria

Inclusion criteria: lack of hypersensitivity to Botox, and satisfaction for enrollment in the study

Exclusion criteria

Exclusion criteria: lack of possibility for follow-up and lack of satisfaction for incorporation in the study

Design outcomes

Primary

Measure	Time frame
family history of major depression first person	—

Secondary

Measure	Time frame
mean duration of disease Second year	—

Countries

iran

Contacts

Public Contactpouria yazdian

Iran University of Medical Sciences, Tehran, Iran

pouria_yazdian_a@yahoo.com09385101025

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026